Skip to content
  • Home
  • JCAD Online
  • Contact Us
  • Home
  • JCAD Online
  • Contact Us

Author: JCADTV Editor

Ted Rosen, MD: New Drugs and Devices at Maui Derm 2023

Dr. Rosen recaps his New Drugs and Devices session delivered at Maui Derm 2023.

Ted Rosen, MD: What’s New in Actinic Keratoses

Dr. Rosen discusses new methods for the treatment and prevention of actinic keratoses, including nicotinamide and a painless protocol for photodynamic therapy.

John Harris, MD, PhD: Developments in JAK Inhibitors for Vitiligo

Dr. Harris discusses the recent research milestones achieved in the JAK inhibitor revolution for vitiligo and what future developments can be expected.

Andy Blauvelt, MD, MBA: Safety Data on JAK Inhibitors for Atopic Dermatitis

Dr. Blauvelt discusses his presentation at Maui Derm 2023, in which he compares new safety data for JAK inhibitors in atopic dermatitis treatment with data from older JAK inhibitors historically used for other diseases.

Lawrence Eichenfield, MD: What’s New in Pediatric Atopic Dermatitis

Dr. Eichenfield recaps his Maui Derm 2023 presentation, in which he discusses developments in pediatric acne.

← Previous
Next →
JCAD | The Journal of Clinical and Aesthetic Dermatology
  • Home
  • JCADOnline
  • Contact Us
  • Terms of Usage and Privacy Policies
  • Home
  • JCADOnline
  • Contact Us
  • Terms of Usage and Privacy Policies


©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.

Facebook Twitter Instagram Envelope